Approval · Notice of Compliance 19113 · 2017
VASOTEC: Notice of Compliance 19113
Issued March 29, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19113
- Date
- March 29, 2017
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Removal of the 2.5 mg tablet
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VASOTEC | Not yet assigned | — |
Medicinal ingredients
- ENALAPRIL MALEATE 4 MG per TAB
- ENALAPRIL MALEATE 8 MG per TAB
- ENALAPRIL MALEATE 16 MG per TAB